Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations


Mitsudomi, T., Morita, S., Yatabe, Y., et al. (2012) Updated Overall Survival Results of WJTOG 3405, a Randomized Phase III Trial Comparing Gefitinib (G) with Cisplatin Plus Docetaxel (CD) as the First-Line Treatment for Patients with Non-Small Cell Lung Cancer Harboring Mutations of the Epidermal Growth Factor Receptor (EGFR). Journal of Clinical Oncology, 30, 7521.

has been cited by the following article: